ResMed Inc. — Cash Flow Charts
12 quarters of history · ending 2026-03-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-4.2% -$25M
$554M
Free Cash Flow↓-6.7% -$37M
$520M
Investing Cash Flow↓-2550.0% -$55M
$-53M
Financing Cash Flow↓-52.7% -$80M
$-230M
Capex↑+61.8% +$13M
$34M
Acquisitions
$25M
Stock Buybacks↑+133.3% +$100M
$175M
Dividends Paid↑+12.3% +$10M
$87M
Stock-Based Comp↑+11.1% +$3M
$27M
Debt Issued
$0
Debt Repaid
$0
D&A↑+35.0% +$15M
$59M
SBC Allocated Expense↑+11.1% +$3M
$27M
SBC Unrecognized Cost↑+35.3% +$21M
$82M